دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Antibiotic Prophylaxis Against Infective Endocarditis Before Invasive Dental Procedures
Martin H. Thornhill, MBBS, BDS, PH D, a,b Teresa B. Gibson, PHD, c Frank Yoon, PHD, c Mark J. Dayer, MBBS, PH D, d Bernard D. Prendergast, BM, BS, DM, e Peter B. Lockhart, DDS, b Patrick T. O’Gara, MD,f Larry M. Baddour, MD
doi : 10.1016/j.jacc.2022.06.030
Volume 80, Issue 11, 13 September 2022, Pages 1029-1041
Antibiotic prophylaxis (AP) before invasive dental procedures (IDPs) is recommended to prevent infective endocarditis (IE) in those at high IE risk, but there are sparse data supporting a link between IDPs and IE or AP efficacy in IE prevention.
Antibiotic Prophylaxis Against Endocarditis Prior to Invasive Dental Procedures: Filling in the Gaps
Ann Bolger, MD, a Dhruv S. Kazi, MD, MSC , MS
doi : 10.1016/j.jacc.2022.07.003
Volume 80, Issue 11, 13 September 2022, Pages 1042-1044
Clinical Outcomes in Patients With Dilated Cardiomyopathy and Ventricular Tachycardia
Katja Zeppenfeld, MD, PHD, a Adrianus P. Wijnmaalen, MD, PH D, a Micaela Ebert, MD,b Samuel H. Baldinger, MD, c,d Antonio Berruezo, MD,e Valentina Catto, P HD, f Marmar Vaseghi, MD, g Arash Arya, MD,b Saurabh Kumar, MD, c Marta de Riva, MD, a Thomas Deneke, MD, h Thomas Gaspar, MD, i Kyoko Soejima, MD, j Nienke van Rein, P HARMD, PHD, k Usha B. Tedrow, MD, c Chistopher Piorkowski, MD,i Kalyanam Shivkumar, MD, g Corrado Carbucicchio, MD, f Gerhard Hindricks, MD,b William G. Stevenson, MD
doi : 10.1016/j.jacc.2022.06.035
Volume 80, Issue 11, 13 September 2022, Pages 1045-1056
Recurrent ventricular tachycardia (VT) due to dilated cardiomyopathy (DCM) is difficult to treat, and long-term outcome data are limited.
Insights From the Dilated Cardiomyopathy Ventricular Tachycardia Ablation Study: Wisdom Through Humility
Wendy S. Tzou, MD
doi : 10.1016/j.jacc.2022.06.033
Volume 80, Issue 11, 13 September 2022, Pages 1057-1059
Outcomes of Repair of Congenital Aortic Valve Lesions Using Autologous Pericardium vs Porcine Intestinal Submucosa
Aditya Sengupta, MD,a Rebecca Beroukhim, MD,b,c Christopher W. Baird, MD, a,d Pedro J. Del Nido, MD,a,d Tal Geva, MD,b,c Kimberlee Gauvreau, SCD, b,e Edward Marcus, MSC ,b Stephen P. Sanders, MD,c,f Meena Nathan, MD, MPH
doi : 10.1016/j.jacc.2022.06.029
Volume 80, Issue 11, 13 September 2022, Pages 1060-1068
Outcomes following congenital aortic valve (AoV) repair are plagued by progressive dysfunction of currently available leaflet substitute materials.
Are There Still Reasons to Use Porcine Small Intestinal Submucosa?
Michael Ma, MD
doi : 10.1016/j.jacc.2022.07.002
Volume 80, Issue 11, 13 September 2022, Pages 1069-1070
Impact of Left Ventricular Ejection Fraction on Clinical Outcomes in Bicuspid Aortic Valve Disease
Sébastien Hecht, MSC ,a, * Steele C. Butcher, MD,b,c, * Stephan M. Pio, MD, b William K.F. Kong, MD, b,d Gurpreet K. Singh, MD, b Arnold C.T. Ng, MD, PHD, e Rebecca Perry, MD, f Kian Keong Poh, MD, d Ana G. Almeida, MD, P HD, g Ariana González, MD, MPH,h Mylène Shen, P HD, a Tiong Cheng Yeo, MD,d Miriam Shanks, MD, PHD, i Bogdan A. Popescu, MD, P HD, j Laura Galian Gay, MD,k Marcin Fijałkowski, MD, PH D, l Michael Liang, MD,m Edgar Tay, MD,d Nina Ajmone Marsan, MD, PH D, b Joseph Selvanayagam, MD, P HD, f Fausto Pinto, MD, PHD, g Jose L. Zamorano, MD, h Arturo Evangelista, MD, k Victoria Delgado, MD, PH D, b Jeroen J. Bax, MD, PH D, b,n Philippe Pibarot, DVM, PHD
doi : 10.1016/j.jacc.2022.06.032
Volume 80, Issue 11, 13 September 2022, Pages 1071-1084
The prognostic impact of left ventricular ejection fraction (LVEF) in patients with bicuspid aortic valve (BAV) disease has not been previously studied.
Left Ventricular Ejection Fraction Thresholds Reappraisal: Also for Bicuspid Valve Disease?∗
Erwan Donal, MD, PH D, a Julien Magne, MD, PH D, b,c Bernard Cosyns, MD, P HD
doi : 10.1016/j.jacc.2022.06.031
Volume 80, Issue 11, 13 September 2022, Pages 1085-1087
Exercise, Cardiovascular Disease, and the Athlete’s Heart
Jason C. Kovacic, MBBS, PHD, a,b,c Valentin Fuster, MD, PH D
doi : 10.1016/j.jacc.2022.07.022
Volume 80, Issue 11, 13 September 2022, Pages 1088-1090
Exercise for Primary and Secondary Prevention of Cardiovascular Disease: JACC Focus Seminar 1/4
Wesley J. Tucker, P HD, RDN, a,b, * Isabel Fegers-Wustrow, MD,c,d, * Martin Halle, MD,c,d Mark J. Haykowsky, P HD, e Eugene H. Chung, MD, MPH, f Jason C. Kovacic, MBBS, P HD
doi : 10.1016/j.jacc.2022.07.004
Volume 80, Issue 11, 13 September 2022, Pages 1091-1106
Regular exercise that meets or exceeds the current physical activity guidelines is associated with a reduced risk of cardiovascular disease (CVD) and mortality. Therefore, exercise training plays an important role in primary and secondary prevention of CVD.
Maternal Health: The Heart of the Matter
Edward T.A. Fry, MD, FACC, President, American College of Cardiology Malissa J. Wood, MD, FACC, Secretary and Board of Governors Chair, American College of Cardiology Mary Norine Walsh, MD, FACC, Past President, American College of Cardiology
doi : 10.1016/j.jacc.2022.08.001
Volume 80, Issue 11, 13 September 2022, Pages 1107-1109
Negotiation for the Early-Career Cardiologist
Simin Gharib Lee, MD, MBA, a Alexander J. Blood, MD, MS C,a,b Ajar Kochar, MD, MHS
doi : 10.1016/j.jacc.2022.06.041
Volume 80, Issue 11, 13 September 2022, Pages 1110-1113
RESPONSE: Last Fair Deal Gone Down
Cam Patterson, MD, MBA
doi : 10.1016/j.jacc.2022.06.042
Volume 80, Issue 11, 13 September 2022, Page 1113
Long-Term Mortality in Obstructive Hypertrophic Cardiomyopathy: Looking Beyond the Assigned Treatment
*George V. Moukarbel, MD Christopher J. Cooper, MD
doi : 10.1016/j.jacc.2022.05.058
Volume 80, Issue 11, 13 September 2022, Page e87
Reply: Long-Term Mortality in Obstructive Hypertrophic Cardiomyopathy: Looking Beyond the Assigned Treatment
Hao Cui, MD *Hartzell V. Schaff, MD
doi : 10.1016/j.jacc.2022.06.034
Volume 80, Issue 11, 13 September 2022, Page e89
